{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:09:51Z","timestamp":1777270191532,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K05-AA014715"],"award-info":[{"award-number":["K05-AA014715"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23-AA02000"],"award-info":[{"award-number":["K23-AA02000"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01-AA016621"],"award-info":[{"award-number":["R01-AA016621"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32-AA015496"],"award-info":[{"award-number":["T32-AA015496"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.biopsych.2012.03.023","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T21:47:32Z","timestamp":1335390452000},"page":"832-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence"],"prefix":"10.1016","volume":"72","author":[{"given":"Lisa M.","family":"Fucito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aesoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzy Bird","family":"Gulliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret E.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralitza V.","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie S.","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2012.03.023_bib1","first-page":"1335","article-title":"Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis","volume":"25","author":"Kranzler","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11920-006-0040-0","article-title":"Choosing the right medication for the treatment of alcoholism","volume":"8","author":"Pettinati","year":"2006","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2012.03.023_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","article-title":"Mediators and moderators of treatment effects in randomized clinical trials","volume":"59","author":"Kraemer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.023_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.023_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1530-0277.2008.00804.x","article-title":"Effects of alcoholism typology on response to naltrexone in the COMBINE study","volume":"33","author":"Bogenschutz","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/alcalc\/agh151","article-title":"Clinical predictors of response to naltrexone in alcoholic patients: Who benefits most from treatment with naltrexone?","volume":"40","author":"Rubio","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1530-0277.2007.00545.x","article-title":"Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment","volume":"32","author":"Tidey","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib8","first-page":"30","article-title":"Type A and type B alcoholism applicability across subpopulations and treatment settings","volume":"20","author":"Ball","year":"1996","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.biopsych.2012.03.023_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.mp.4000556","article-title":"Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: Population studies, and allele frequencies in alcohol- and drug-dependent subjects","volume":"4","author":"Gelernter","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.023_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.023_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/archinte.167.7.716","article-title":"Smoking status is a clinical indicator for alcohol misuse in US adults","volume":"167","author":"McKee","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2012.03.023_bib12","series-title":"Treating Tobacco Use and Dependence, 2008 Update","author":"Fiore","year":"2008"},{"key":"10.1016\/j.biopsych.2012.03.023_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0005-7894(05)80386-7","article-title":"Smoking and treatment outcome for alcoholics: Effects on coping skills, urge to drink, and drinking rates","volume":"23","author":"Abrams","year":"1992","journal-title":"Behav Ther"},{"key":"10.1016\/j.biopsych.2012.03.023_bib14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.addbeh.2007.06.006","article-title":"Long-term behavior in treated alcoholism: Evidence for beneficial carry-over effects of abstinence from smoking on alcohol use and vice versa","volume":"32","author":"Hintz","year":"2007","journal-title":"Addict Behav"},{"key":"10.1016\/j.biopsych.2012.03.023_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1530-0277.2009.00925.x","article-title":"Naltrexone decreases heavy drinking rates in smoking cessation treatment: An exploratory study","volume":"33","author":"King","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S146114570800936X","article-title":"Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation","volume":"12","author":"O'Malley","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/ADM.0b013e3181917d53","article-title":"Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacy","volume":"3","author":"Mason","year":"2009","journal-title":"J Addict Med"},{"key":"10.1016\/j.biopsych.2012.03.023_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2009.08.009","article-title":"Addressing tobacco use disorder in smokers in early remission from alcohol dependence: The case for integrating smoking cessation services in substance use disorder treatment programs","volume":"30","author":"Kalman","year":"2010","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.biopsych.2012.03.023_bib19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1037\/0022-006X.72.6.1144","article-title":"A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery","volume":"72","author":"Prochaska","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2009.05.025","article-title":"Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients","volume":"105","author":"Baltieri","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.03.023_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/1462220031000073298","article-title":"Naltrexone treatment for alcoholics: Effect on cigarette smoking rates","volume":"5","author":"Rohsenow","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib22","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2012.03.023_bib23","first-page":"217","article-title":"Advances in the use of naltrexone: An integration of preclinical and clinical findings","volume":"16","author":"O'Malley","year":"2003","journal-title":"Recent Dev Alcohol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.15288\/jsa.1997.58.358","article-title":"The reliability of Form 90: An instrument for assessing alcohol treatment outcome","volume":"58","author":"Tonigan","year":"1997","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib25","series-title":"Alcohol Consumption Measures","author":"Sobell","year":"2003"},{"key":"10.1016\/j.biopsych.2012.03.023_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsat.2005.07.001","article-title":"Changes in cigarette consumption and drinking outcomes: Findings from Project MATCH","volume":"29","author":"Friend","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.biopsych.2012.03.023_bib27","series-title":"The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse","author":"Miller","year":"1995"},{"key":"10.1016\/j.biopsych.2012.03.023_bib28","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders Research Version","author":"First","year":"2002"},{"key":"10.1016\/j.biopsych.2012.03.023_bib29","series-title":"Alcohol Dependence Scale: User's Guide","author":"Skinner","year":"1984"},{"key":"10.1016\/j.biopsych.2012.03.023_bib30","series-title":"Applied Longitudinal Analysis","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.biopsych.2012.03.023_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/alcalc\/agm027","article-title":"Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers","volume":"42","author":"Schmidt","year":"2007","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J069v24n02_06","article-title":"Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders","volume":"24","author":"Friend","year":"2005","journal-title":"J Addict Dis"},{"key":"10.1016\/j.biopsych.2012.03.023_bib33","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1360-0443.2009.02624.x","article-title":"Smoking cessation during alcohol treatment: A randomized trial of combination nicotine patch plus nicotine gum","volume":"104","author":"Cooney","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2012.03.023_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biopsych.2009.01.029","article-title":"Varenicline reduces alcohol self-administration in heavy-drinking smokers","volume":"66","author":"McKee","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2012.03.023_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00213-010-2160-9","article-title":"A preliminary investigation of varenicline for heavy drinking smokers","volume":"215","author":"Fucito","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.023_bib36","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/archinte.165.14.1600","article-title":"Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: A randomized controlled trial","volume":"165","author":"Johnson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.biopsych.2012.03.023_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/105504901750532148","article-title":"Predicting treatment response to naltrexone: The influence of craving and family history","volume":"10","author":"Monterosso","year":"2001","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2012.03.023_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/1064-1297.15.3.272","article-title":"Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics","volume":"15","author":"Rohsenow","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000083037","article-title":"Pharmacological relapse prevention of alcoholism: Clinical predictors of outcome","volume":"11","author":"Kiefer","year":"2005","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.physbeh.2011.04.043","article-title":"The reinforcement-enhancing effects of nicotine: Implications for the relationship between smoking, eating, and weight","volume":"104","author":"Donny","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2012.03.023_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00213-007-0899-4","article-title":"Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues","volume":"195","author":"L\u00f6f","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.023_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresrev.2004.08.005","article-title":"Cue reactivity in nicotine and tobacco dependence: A \u201cmultiple-action\u201d model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli","volume":"48","author":"Chiamulera","year":"2005","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.biopsych.2012.03.023_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: A common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2012.03.023_bib44","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.1201889","article-title":"Nicotine decreases food intake through activation of POMC neurons","volume":"332","author":"Mineur","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2012.03.023_bib45","doi-asserted-by":"crossref","first-page":"804296","DOI":"10.1155\/2011\/804296","article-title":"Low-dose naltrexone for pruritus in systemic sclerosis","volume":"2011","author":"Frech","year":"2011","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","article-title":"Low-dose naltrexone for disease prevention and quality of life","volume":"72","author":"Brown","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopsych.2012.03.023_bib47","doi-asserted-by":"crossref","first-page":"507","DOI":"10.15288\/jsad.2011.72.507","article-title":"Problem drinking and low-dose naltrexone-assisted opioid detoxification","volume":"72","author":"Mannelli","year":"2011","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.biopsych.2012.03.023_bib48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1572-0241.2007.01045.x","article-title":"Low-dose naltrexone therapy improves active Crohn's disease","volume":"102","author":"Smith","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.biopsych.2012.03.023_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/1462220031000158645","article-title":"Smoking topography: Reliability and validity in dependent smokers","volume":"5","author":"Lee","year":"2003","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.biopsych.2012.03.023_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130051027","article-title":"Smoking behaviour and compensation: A review of the literature","volume":"145","author":"Scherer","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2012.03.023_bib51","first-page":"193","article-title":"Cancer risk associated with alcohol and tobacco use: Focus on upper aero-digestive tract and liver","volume":"29","author":"Pelucchi","year":"2006","journal-title":"Alcohol Res Health"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322312003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:56:55Z","timestamp":1757775415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322312003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0006322312003009"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.03.023","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2012.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}